Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxyacid oxidase (glycolate oxidase) 1 is a peroxisomal enzyme, encoded by the HAO1 gene and primarily expressed in the liver and pancreas, that catalyzes the oxidation of glycolate to glyoxylate as part of glyoxylate metabolism. By facilitating the conversion of glycolate, the enzyme plays a key role in the regulation of oxalate production. Aberrant HAO1 activity can lead to pathological accumulation of oxalate, predisposing to disorders such as primary hyperoxaluria and kidney stones. The enzyme can also oxidize other 2-hydroxy acids with lower catalytic efficiency and is implicated as a potential therapeutic target for diseases related to oxalate metabolism[1][2][6][8].
Enzyme inhibition reduces oxidation of glycolate to glyoxylate, lowering oxalate production and potentially reducing risk of calcium oxalate kidney stones and systemic oxalosis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxyacid oxidase (glycolate oxidase) 1 (HAO1).